thanks our CNS team for your great effort
Last week, City Pharmaceutical Company reinforced our commitment to both patients and the healthcare professionals who care for them in the field of Migraine. We were privileged to participate in key events, dedicated to advancing knowledge and improving patient outcomes. As a main sponsor and active participant in the 5th Dubai Neurology Congress, we facilitated critical discussions with leading neurologists, sharing the latest research and advancements aimed at enhancing Migraine care. This platform provided invaluable opportunities for HCPs to deepen their understanding of cutting-edge therapies for Migraine prevention. Our involvement in NeuroClub meetings along with our initiated speaker-led sessions was centered around providing HCPs with practical, actionable insights. These educational sessions, led by esteemed experts, focused on translating the latest scientific breakthroughs into improved patient care. We aimed to empower HCPs with the tools and knowledge necessary to optimize treatment strategies and ultimately, enhance the quality of life for the Migraine patients. We're inspired by the dedication of the neurology community and The Emirates Neurology Society. City Pharmaceutical Co. is committed to continuing our support for HCP education and working alongside them to bring the most effective and innovative neurological care to patients. We believe that by empowering HCPs with knowledge, we directly contribute to better patient outcomes.
-
-
-
-
-
+3